UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well‐being in men and women: results from the EPIC study

BJU international, 2008-06, Vol.101 (11), p.1388-1395

2008

Volltextzugriff (PDF)

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study

European urology, 2006-12, Vol.50 (6), p.1306-1315

2006

Volltextzugriff (PDF)

A Narrative Review of Patient-reported Outcomes in Overactive Bladder: What is the Way of the Future?

European urology, 2016-11, Vol.70 (5), p.799-805

2016

Volltextzugriff (PDF)

Bladder function after radical hysterectomy for cervical cancer

Neurourology and urodynamics, 2015-04, Vol.34 (4), p.309-315

2015

Volltextzugriff (PDF)

The economic impact of overactive bladder syndrome in six Western countries

BJU international, 2009-01, Vol.103 (2), p.202-209

2009

Volltextzugriff (PDF)

Waterbirth and pelvic floor injury: a retrospective study and postal survey using ICIQ modular long form questionnaires

European journal of obstetrics & gynecology and reproductive biology, 2011-03, Vol.155 (1), p.27-30

2011

Volltextzugriff (PDF)

Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta‐analysis

Neurourology and urodynamics, 2018-03, Vol.37 (3), p.986-996

2018

Volltextzugriff (PDF)

Impact of fesoterodine on quality of life: pooled data from two randomized trials

BJU international, 2008-07, Vol.102 (1), p.56-61

2008

Volltextzugriff (PDF)

Multinational Study of Reliability and Validity of the King's Health Questionnaire in Patients with Overactive Bladder

Quality of life research, 2003-06, Vol.12 (4), p.427-442

2003

Volltextzugriff (PDF)

Effects of drug cessation after flexible‐dose fesoterodine in patients with overactive bladder

BJU international, 2013-10, Vol.112 (6), p.820-829

2013

Volltextzugriff (PDF)

Improved quality of life in patients with overactive bladder symptoms treated with solifenacin

BJU international, 2005-01, Vol.95 (1), p.81-85

2005

Volltextzugriff (PDF)

Overactive Bladder Is Associated with Erectile Dysfunction and Reduced Sexual Quality of Life in Men

Journal of sexual medicine, 2008-12, Vol.5 (12), p.2904-2910

2008

Volltextzugriff (PDF)

How much is enough and who says so? The case of the King's Health Questionnaire and overactive bladder

BJOG : an international journal of obstetrics and gynaecology, 2004-06, Vol.111 (6), p.605-612

2004

Volltextzugriff (PDF)

Sustained improvement in patient‐reported outcomes during long‐term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open‐label extension studies

BJU international, 2012-08, Vol.110 (3), p.392-400

2012

Volltextzugriff (PDF)

Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms

Current medical research and opinion, 2011-05, Vol.27 (5), p.921-930

2011

Volltextzugriff (PDF)

Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo

Health and quality of life outcomes, 2009-02, Vol.7 (1), p.13-13, Article 13

2009

Volltextzugriff (PDF)

Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis

European urology, 2018-09, Vol.74 (3), p.324-333

2018

Volltextzugriff (PDF)

Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK

Journal of market access & health policy, 2018, Vol.6 (1), p.1438721-11

2018

Volltextzugriff (PDF)

Clinical value of a patient-reported goal-attainment measure: the global development of self-assessment goal achievement (SAGA) questionnaire for patients with lower urinary tract symptoms

Neurourology and urodynamics, 2014-01, Vol.33 (1), p.90-94

2014

Volltextzugriff (PDF)

A review of solifenacin in the treatment of urinary incontinence

Therapeutics and clinical risk management, 2008-02, Vol.4 (1), p.117-128

2008

Volltextzugriff (PDF)

The Validation of Patient-Rated Global Assessments of Treatment Benefit, Satisfaction, and Willingness to Continue—The BSW

Value in health, 2005-11, Vol.8, p.S25-S34

2005

Volltextzugriff (PDF)

Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire

International Urogynecology Journal, 2011-08, Vol.22 (8), p.937-946

2011

Volltextzugriff (PDF)

Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence

International Urogynecology Journal, 2006-08, Vol.17 (4), p.382-388

2006

Volltextzugriff (PDF)

European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder

International Urogynecology Journal, 2013-09, Vol.24 (9), p.1529-1536

2013

Volltextzugriff (PDF)

Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony)

European urology, 2015-03, Vol.67 (3), p.577-588

2015

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(86)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Humans
(51)
Female
(42)
Male
(33)
Urology & Nephrology
(33)
Overactive Bladder
(32)
Quality Of Life
(30)
Middle Aged
(29)
Aged
(27)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Adult
(21)
Nephrology. Urinary Tract Diseases
(20)
Surveys And Questionnaires
(20)
Treatment Outcome
(19)
Urinary System Involvement In Other Diseases. Miscellaneous
(19)
Urinary Tract. Prostate Gland
(19)
Urinary Bladder, Overactive - Drug Therapy
(15)
Muscarinic Antagonists - Therapeutic Use
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well‐being in men and women: results from the EPIC study

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study

A Narrative Review of Patient-reported Outcomes in Overactive Bladder: What is the Way of the Future?

Bladder function after radical hysterectomy for cervical cancer

The economic impact of overactive bladder syndrome in six Western countries

Waterbirth and pelvic floor injury: a retrospective study and postal survey using ICIQ modular long form questionnaires

Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta‐analysis

Impact of fesoterodine on quality of life: pooled data from two randomized trials

Multinational Study of Reliability and Validity of the King's Health Questionnaire in Patients with Overactive Bladder

Effects of drug cessation after flexible‐dose fesoterodine in patients with overactive bladder

Improved quality of life in patients with overactive bladder symptoms treated with solifenacin

Overactive Bladder Is Associated with Erectile Dysfunction and Reduced Sexual Quality of Life in Men

How much is enough and who says so? The case of the King's Health Questionnaire and overactive bladder

Sustained improvement in patient‐reported outcomes during long‐term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open‐label extension studies

Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms

Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo

Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis

Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK

Clinical value of a patient-reported goal-attainment measure: the global development of self-assessment goal achievement (SAGA) questionnaire for patients with lower urinary tract symptoms

A review of solifenacin in the treatment of urinary incontinence

The Validation of Patient-Rated Global Assessments of Treatment Benefit, Satisfaction, and Willingness to Continue—The BSW

Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire

Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence

European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder

Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony)

Suchergebnisse filtern